undefined
EUTM file information

018484341

Ori


May 31, 2021

Trademark Summary

The trademark application Ori was filed by Oribiotech Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on August 31, 2021, and it was registered by office on December 8, 2021 without any oppositions.

The application was filed in English (German was selected as the second language).

Creation of rights in rem of the trademark registration was recorded on December 7, 2022. Change of name and address of the trademark registration was recorded on January 15, 2024. Change of name and professional address of the trademark registration was recorded on February 25, 2024.


Goods And Services

  • The mark was filed in class 35 with Commercial consultancy in relation to cell culture, cell therapy, or gene therapy manufacturing and information, advice and consultancy in relation to all the aforesaid..
  • The mark was filed in class 42 with following description of goods:
    1. Software as a service (SaaS), non-downloadable software, software platforms and platform as a services in the field of cell therapy, gene therapy or cell culture
    2. Software as a service (SaaS), non-downloadable software, software platforms and platform as a services for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment for cell culture, cell therapy or gene therapy
    3. Software as a service (SaaS), non-downloadable software, software platforms and platform as a services for controlling, monitoring, programming and adjusting environmental conditions for cell culture, cell therapy or gene therapy
    4. Software as a service (SaaS), non-downloadable software, software platforms and platform as a services for logging data in relation to cell culture, cell therapy or gene therapy
    5. Software as a service (SaaS), non-downloadable software, software platforms and platform as a services for monitoring patent health
    6. Software as a service (SaaS), non-downloadable software, software platforms and platform as a services for providing information on cell culture, cell therapy or gene therapy
    7. Research, design and development services in biotechnology
    8. Design and development of scientific cell culture, cell therapy or gene therapy equipment and apparatus
    9. Design and development of cell culture, cell therapy or gene therapy manufacturing equipment, manufacturing systems and manufacturing processes for others
    10. Development of cell culture, cell therapy or gene therapy processes for others
    11. Scientific consultancy in relation to cell culture, cell therapy, or gene therapy manufacturing
    12. Rental and leasing of scientific cell culture, cell therapy and gene therapy apparatus and equipment
    13. Information, advice and consultancy in relation to all the aforesaid.